(Q39329856)

English

DNA and adenovirus tumor vaccine expressing truncated survivin generates specific immune responses and anti-tumor effects in a murine melanoma model

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

DNA and adenovirus tumor vaccine expressing truncated survivin generates specific immune responses and anti-tumor effects in a murine melanoma model (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

1 reference

based on heuristic

inferred from title

author name string

Haihong Zhang

1

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Yuqian Wang

2

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Chenlu Liu

3

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Lixing Zhang

4

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Qiu Xia

5

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Yong Zhang

6

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Jiaxin Wu

7

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Chunlai Jiang

8

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Yan Chen

9

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Yongge Wu

10

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Xiao Zha

11

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Xianghui Yu

12

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Wei Kong

13

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

publication date

17 June 2012

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Cancer Immunology, Immunotherapy

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

61

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

1857-1867

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

https://scigraph.springernature.com/pub.10.1007/s00262-012-1296-3

0 references

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1296-3

21 January 2018

Improvement of different vaccine delivery systems for cancer therapy

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1296-3

21 January 2018

Survivin, cancer networks and pathway-directed drug discovery.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1296-3

21 January 2018

Modified vaccinia Ankara expressing survivin combined with gemcitabine generates specific antitumor effects in a murine pancreatic carcinoma model.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1296-3

21 January 2018

Efficient co-transduction of adenoviral vectors encoding carcinoembryonic antigen and survivin into dendritic cells by the CAR-TAT adaptor molecule enhance anti-tumor immunity in a murine colorectal cancer model

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1296-3

21 January 2018

Intradermal DNA electroporation induces survivin-specific CTLs, suppresses angiogenesis and confers protection against mouse melanoma

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1296-3

21 January 2018

Cytokine regulation of natural killer cell effector functions

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1296-3

21 January 2018

Naked DNA immunization as an approach to target the generic tumor antigen survivin induces humoral and cellular immune responses in mice

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1296-3

21 January 2018

Survivin DNA vaccine generated specific antitumor effects in pancreatic carcinoma and lymphoma mouse models

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1296-3

21 January 2018

Adenovirus vector-based vaccines for human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1296-3

21 January 2018

Mucosal prior to systemic application of recombinant adenovirus boosting is more immunogenic than systemic application twice but confers similar protection against SIV-challenge in DNA vaccine-primed macaques.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1296-3

21 January 2018

Cancer treatment: the combination of vaccination with other therapies

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1296-3

21 January 2018

A rapid and simple method for the isolation of apoptotic DNA fragments.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1296-3

21 January 2018

Pleiotropic cell-division defects and apoptosis induced by interference with survivin function

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1296-3

21 January 2018

Expression and targeting of the apoptosis inhibitor, survivin, in human melanoma

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1296-3

21 January 2018

Regulation of apoptosis at cell division by p34cdc2 phosphorylation of survivin

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1296-3

21 January 2018

Detection of autoantibodies to survivin and livin in sera from patients with breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1296-3

21 January 2018

Immunogenic enhancement and clinical effect by type-I interferon of anti-apoptotic protein, survivin-derived peptide vaccine, in advanced colorectal cancer patients

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1296-3

21 January 2018

Phase I clinical trial of survivin-derived peptide vaccine therapy for patients with advanced or recurrent oral cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1296-3

21 January 2018

Phase I clinical study of anti-apoptosis protein survivin-derived peptide vaccination for patients with advanced or recurrent urothelial cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1296-3

21 January 2018

Phase I clinical study of anti-apoptosis protein, survivin-derived peptide vaccine therapy for patients with advanced or recurrent colorectal cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1296-3

21 January 2018

Vaccination with autologous dendritic cells pulsed with multiple tumor antigens for treatment of patients with malignant melanoma: results from a phase I/II trial

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1296-3

21 January 2018

Immunization of NSCLC patients with antigen-pulsed immature autologous dendritic cells

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1296-3

21 January 2018

Structure of the human anti-apoptotic protein survivin reveals a dimeric arrangement

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1296-3

21 January 2018

Crystal structure of human survivin reveals a bow tie-shaped dimer with two unusual alpha-helical extensions

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1296-3

21 January 2018

Survivin structure: crystal unclear.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1296-3

21 January 2018

Safety and reactogenicity of canarypox ALVAC-HIV (vCP1521) and HIV-1 gp120 AIDSVAX B/E vaccination in an efficacy trial in Thailand

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1296-3

21 January 2018

Identifiers

10.1007/S00262-012-1296-3

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39329856&oldid=1820259200"